Chapter 8: Variation in Chromosome Structure and Number
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Structural chromosomal variations include deletions, where segments of DNA are lost from a chromosome, duplications that create extra copies of genetic material and may establish gene families or produce dosage imbalances, inversions in which chromosome segments are reversed and can suppress recombination between homologous regions, and translocations where material shifts between nonhomologous chromosomes. Reciprocal translocations involve balanced exchanges of genetic material between two chromosomes and can produce unbalanced gametes during meiosis, leading to semisterility in carriers. Robertsonian translocations, a special category in which two acrocentric chromosomes fuse at their centromeres, represent a frequent mechanism underlying familial Down syndrome. The chapter then addresses numerical chromosome abnormalities through aneuploidy, an irregular number of individual chromosomes typically arising from nondisjunction during meiosis I or II, when chromosomes fail to separate properly into daughter cells. Classic aneuploidies include trisomy 21 causing Down syndrome and monosomy X underlying Turner syndrome; viability of aneuploid individuals correlates with chromosome size and gene content, as smaller chromosomes generate less severe dosage imbalance. In contrast, euploidy describes conditions in which entire chromosome sets are present in abnormal numbers, encompassing polyploidy where organisms carry three or more complete sets. Although polyploidy is typically lethal in animals, it occurs frequently in plants and drives speciation and agricultural improvement through autopolyploidy and allopolyploidy. The chapter explores polyploid formation via endoreplication and nondisjunction of complete sets, and describes artificial polyploid induction using colchicine for crop development. These chromosomal changes illustrate critical mechanisms in cancer development, evolutionary adaptation, and biotechnology applications.